Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value

Multiple myeloma (MM) is a malignant neoplasm characterized by clonal proliferation of abnormal plasma cells. In many countries, it ranks as the second most prevalent malignant neoplasm of the hematopoietic system. Although treatment methods for MM have been continuously improved and the survival of...

Full description

Bibliographic Details
Main Authors: Jun Du, Xiao-Ran Gu, Xiao-Xiao Yu, Yang-Jia Cao, Jian Hou
Format: Article
Language:English
Published: Wolters Kluwer Health 2023-10-01
Series:Blood Science
Online Access:http://journals.lww.com/10.1097/BS9.0000000000000172
_version_ 1797449543733739520
author Jun Du
Xiao-Ran Gu
Xiao-Xiao Yu
Yang-Jia Cao
Jian Hou
author_facet Jun Du
Xiao-Ran Gu
Xiao-Xiao Yu
Yang-Jia Cao
Jian Hou
author_sort Jun Du
collection DOAJ
description Multiple myeloma (MM) is a malignant neoplasm characterized by clonal proliferation of abnormal plasma cells. In many countries, it ranks as the second most prevalent malignant neoplasm of the hematopoietic system. Although treatment methods for MM have been continuously improved and the survival of patients has been dramatically prolonged, MM remains an incurable disease with a high probability of recurrence. As such, there are still many challenges to be addressed. One promising approach is single-cell RNA sequencing (scRNA-seq), which can elucidate the transcriptome heterogeneity of individual cells and reveal previously unknown cell types or states in complex tissues. In this review, we outlined the experimental workflow of scRNA-seq in MM, listed some commonly used scRNA-seq platforms and analytical tools. In addition, with the advent of scRNA-seq, many studies have made new progress in the key molecular mechanisms during MM clonal evolution, cell interactions and molecular regulation in the microenvironment, and drug resistance mechanisms in target therapy. We summarized the main findings and sequencing platforms for applying scRNA-seq to MM research and proposed broad directions for targeted therapies based on these findings.
first_indexed 2024-03-09T14:26:33Z
format Article
id doaj.art-1fe7405db3f04f6b96dd612b49048aa5
institution Directory Open Access Journal
issn 2543-6368
language English
last_indexed 2024-03-09T14:26:33Z
publishDate 2023-10-01
publisher Wolters Kluwer Health
record_format Article
series Blood Science
spelling doaj.art-1fe7405db3f04f6b96dd612b49048aa52023-11-28T07:05:42ZengWolters Kluwer HealthBlood Science2543-63682023-10-015422123610.1097/BS9.0000000000000172202312000-00001Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational valueJun Du0Xiao-Ran Gu1Xiao-Xiao Yu2Yang-Jia Cao3Jian Hou4a Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, Chinab School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, Chinab School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, Chinac Department of Hematology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shanxi 710000, Chinaa Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaMultiple myeloma (MM) is a malignant neoplasm characterized by clonal proliferation of abnormal plasma cells. In many countries, it ranks as the second most prevalent malignant neoplasm of the hematopoietic system. Although treatment methods for MM have been continuously improved and the survival of patients has been dramatically prolonged, MM remains an incurable disease with a high probability of recurrence. As such, there are still many challenges to be addressed. One promising approach is single-cell RNA sequencing (scRNA-seq), which can elucidate the transcriptome heterogeneity of individual cells and reveal previously unknown cell types or states in complex tissues. In this review, we outlined the experimental workflow of scRNA-seq in MM, listed some commonly used scRNA-seq platforms and analytical tools. In addition, with the advent of scRNA-seq, many studies have made new progress in the key molecular mechanisms during MM clonal evolution, cell interactions and molecular regulation in the microenvironment, and drug resistance mechanisms in target therapy. We summarized the main findings and sequencing platforms for applying scRNA-seq to MM research and proposed broad directions for targeted therapies based on these findings.http://journals.lww.com/10.1097/BS9.0000000000000172
spellingShingle Jun Du
Xiao-Ran Gu
Xiao-Xiao Yu
Yang-Jia Cao
Jian Hou
Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value
Blood Science
title Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value
title_full Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value
title_fullStr Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value
title_full_unstemmed Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value
title_short Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value
title_sort essential procedures of single cell rna sequencing in multiple myeloma and its translational value
url http://journals.lww.com/10.1097/BS9.0000000000000172
work_keys_str_mv AT jundu essentialproceduresofsinglecellrnasequencinginmultiplemyelomaanditstranslationalvalue
AT xiaorangu essentialproceduresofsinglecellrnasequencinginmultiplemyelomaanditstranslationalvalue
AT xiaoxiaoyu essentialproceduresofsinglecellrnasequencinginmultiplemyelomaanditstranslationalvalue
AT yangjiacao essentialproceduresofsinglecellrnasequencinginmultiplemyelomaanditstranslationalvalue
AT jianhou essentialproceduresofsinglecellrnasequencinginmultiplemyelomaanditstranslationalvalue